Malotilate
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
diisopropyl 1,3-dithiol-2-ylidenemalonate | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| Legal status |
|
| Identifiers | |
| CAS Number |
59937-28-9 |
| ATC code | none |
| PubChem | CID 4006 |
| ChemSpider |
3866 |
| UNII |
RV59PND975 |
| ChEMBL |
CHEMBL1697754 |
| Chemical data | |
| Formula | C12H16O4S2 |
| Molar mass | 288.38 g/mol |
| |
| |
| | |
Malotilate (INN) is a drug used in the treatment of liver disease. It has been shown to facilitate liver regeneration in rats.[1]
References
- Bührer M, Le Cotonnec JY, Wermeille M, Bircher J (1986). "Treatment of liver disease with malotilate. A pharmacokinetic and pharmacodynamic phase II study in cirrhosis". Eur. J. Clin. Pharmacol. 30 (4): 407–16. doi:10.1007/BF00607952. PMID 3743616.
- Siegers CP, Pauli V, Korb G, Younes M (August 1986). "Hepatoprotection by malotilate against carbon tetrachloride-alcohol-induced liver fibrosis". Agents Actions 18 (5–6): 600–3. doi:10.1007/BF01964970. PMID 3766314.
- Younes M, Siegers CP (May 1985). "Effect of malotilate on paracetamol-induced hepatotoxicity". Toxicol. Lett. 25 (2): 143–6. doi:10.1016/0378-4274(85)90074-8. PMID 4002245.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
